Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Non-Current Deffered Revenue (2020 - 2022)

RAPT Therapeutics' Non-Current Deffered Revenue history spans 2 years, with the latest figure at $2.2 million for Q4 2021.

  • For Q4 2021, Non-Current Deffered Revenue rose 149.13% year-over-year to $2.2 million; the TTM value through Dec 2021 reached $2.2 million, up 149.13%, while the annual FY2021 figure was $2.2 million, 149.13% up from the prior year.
  • Non-Current Deffered Revenue for Q4 2021 was $2.2 million at RAPT Therapeutics, up from $745000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $2.2 million in Q1 2020 and bottomed at $745000.0 in Q3 2021.